Esin ÖZKAN, Hüseyin ÖZKAN, Serkan BİLGİÇ, Ersin ODABAŞI, Nuray CAN, Emin Özgür AKGÜL, İbrahim YANMIŞ, Yüksel YURTTAŞ, Mustafa KÜRKLÜ, Mustafa BAŞBOZKURT, Mehmet Kemal ERBİL

Serum fetuin-A levels in postmenopausal women with osteoporosis

One of the functions of fetuin-A is the restriction of formation and expansion of extraosseous hydroxyapatite crystals. The exact correlation of fetuin-A with bone mineral density (BMD) has not been clearly elucidated yet. In this study, we aimed to assess the relationship between BMD and fetuin-A in postmenopausal women. Materials and methods: Fifty postmenopausal women (25 with osteoporosis, 25 healthy controls) were included in the study. All participants were comparable for age and body mass index. None of the osteoporotic patients had received any medical treatment for osteoporosis. Serum fetuin-A levels were measured by ELISA method. Results: BMD scores of the groups were statistically significant (P < 0.001). Serum fetuin-A levels of the osteoporosis group were significantly lower compared to the control group (P = 0.009). Additionally, there was there was a mild to moderate positive correlation between fetuin-A and lumbar (r = 0.381, P = 0.06) and femoral (r = 0.143, P = 0.50) BMD in the osteoporotic group, though it did not reach statistical significance. Conclusion: Decreased fetuin-A levels in women with postmenopausal osteoporosis suggest that fetuin-A may have a role in the development of osteoporosis. Further studies are required to define the exact role of fetuin-A in bone metabolism.

Anahtar Kelimeler:

Fetuin-A, bone mineral density, osteoporosis

Serum fetuin-A levels in postmenopausal women with osteoporosis

Keywords:

Fetuin-A, bone mineral density, osteoporosis,

PDF

___

Pickett W, Hartling L, Brison RJ. Population-based study of hospitalized injuries in Kingston, Ontario, identified via the Canadian Hospitals Injury Reporting and Prevention Program. Chronic Dis Can 1997; 18: 61–69.
Canbal M, Şencan İ, Şahin A, Kunt Ş, Çavuş UY, Tekin O. Effects of depression and life factors on social network score in elderly people in Çankaya, Ankara. Turk J Med Sci 2012; 42: 725–731.
Ix JH, Wassel CL, Bauer DC, Toroian D, Tylavsky FA, Cauley JA, Harris TB, Price PA, Cummings SR, Shlipak MG. Fetuin-A and bone mineral density in older persons: The Health Aging and Body Composition (Health ABC) study. J Bone Miner Res 2009; 24: 514–521.
Schlieper G, Westenfeld R, Brandenburg V, Ketteler M. Inhibitors of calcification in blood and urine. Semin Dial 2007; 20: 113–121. 9. Heiss A, DuChesne A, Denecke B, Grotzinger J, Yamamoto K, Renne T, Jahnen-Dechent W. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 2003; 278: 13333– 13341.
Quelch KJ, Cole WG, Melick RA. Non-collagenous proteins in normal and pathological human bone. Calcif Tissue Int 1984; 36: 545–549.
Ketteler M, Bongartz P, Westenfeld R, Wildberger J, Mahnken A, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827–833.
Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, Jahnen-Dechent W, Shanahan CM. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 2005; 16: 2920–2930.
Toroian D, Lim JE, Price PA. The size exclusion characteristics of type I collagen: implications for the role of non-collagenous bone constituents in mineralization. J Biol Chem 2007; 282: 22,437–22,447.
Chailurkit L, Kruavit A, Rajatanavin R, Ongphiphadhanakul B. The relationship of fetuin-A and lactoferrin with bone mass in elderly women. Osteoporos Int 2011; 22: 2159–2164.
World Health Organization. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis: Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1994.
Binkert C, Demetriou M, Sukhu B, Szweras M, Tenenbaum HC, Dennis JW. Regulation of osteogenesis by fetuin. J Biol Chem 1999; 274: 28514–28520.
Toroian D, Price PA. The essential role of fetuin in the serum- induced calcification of collagen. Calcif Tissue Int 2008; 82: 116–126.
Szweras M, Liu D, Partridge EA, Pawling J, Sukhu B, Clokie C, Jahnen-Dechent W, Tenenbaum HC, Swallow CJ, Grynpas MD et al. Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 2002; 277: 19991–19997.